All products and services are For Research Use Only and CANNOT be used in the treatment or diagnosis of disease.
CAT | Product Name | Target Species | Antibody Clone | Antibody Host | Receptor Construction | Vector Type | Targeting Cell Type | CAR Vector Type | Inquiry & Datasheet |
XS-0822-YF2116 | Anti-Human CLDN18.2 (XW-276) h(CD28-41BB-CD3ζ) CAR IVT Plasmid, pCARIVT | Human | XW-276 | Mouse | scFv-CD28-41BB-CD3ζ | In Vitro Transcription (IVT) Vector | |||
XS-0822-YF2117 | Anti-Mouse CLDN18.2 (XW-277) m(CD28-41BB-CD3ζ) CAR IVT Plasmid, pCARIVT | Mouse | XW-277 | Rat | scFv-CD28-41BB-CD3ζ | In Vitro Transcription (IVT) Vector | |||
XS-0822-YF2118 | Anti-Human CLDN18.2 (XW-278) h(CD28-41BB-CD3ζ) CAR IVT Plasmid, pCARIVT | Human | XW-278 | Mouse | scFv-CD28-41BB-CD3ζ | In Vitro Transcription (IVT) Vector | |||
XS-0822-YF2119 | Anti-Human CLDN18.2 (XW-279) h(CD28-41BB-CD3ζ) CAR IVT Plasmid, pCARIVT | Human | XW-279 | Mouse | scFv-CD28-41BB-CD3ζ | In Vitro Transcription (IVT) Vector | |||
XS-0822-YF2120 | Anti-Human CLDN18.2 (XW-280) h(CD28-41BB-CD3ζ) CAR IVT Plasmid, pCARIVT | Human | XW-280 | Mouse | scFv-CD28-41BB-CD3ζ | In Vitro Transcription (IVT) Vector | |||
XS-0822-YF2121 | Anti-Mouse CLDN18.2 (XW-281) m(CD28-41BB-CD3ζ) CAR IVT Plasmid, pCARIVT | Mouse | XW-281 | Rat | scFv-CD28-41BB-CD3ζ | In Vitro Transcription (IVT) Vector | |||
XS-0822-YF2122 | Anti-Human CLDN18.2 (XW-282) h(CD28-41BB-CD3ζ) CAR IVT Plasmid, pCARIVT | Human | XW-282 | Mouse | scFv-CD28-41BB-CD3ζ | In Vitro Transcription (IVT) Vector | |||
XS-0822-YF2123 | Anti-Human CLDN18.2 (XW-283) h(CD28-41BB-CD3ζ) CAR IVT Plasmid, pCARIVT | Human | XW-283 | Humanized | scFv-CD28-41BB-CD3ζ | In Vitro Transcription (IVT) Vector | |||
XS-0822-YF2124 | Anti-Human CLDN18.2 (XW-284) h(CD28-41BB-CD3ζ) CAR IVT Plasmid, pCARIVT | Human | XW-284 | Humanized | scFv-CD28-41BB-CD3ζ | In Vitro Transcription (IVT) Vector | |||
XS-0822-YF2125 | Anti-Human CLDN18.2 (XW-285) h(CD28-41BB-CD3ζ) CAR IVT Plasmid, pCARIVT | Human | XW-285 | Mouse | scFv-CD28-41BB-CD3ζ | In Vitro Transcription (IVT) Vector | |||
XS-0822-YF8358 | TS-Fluc Anti-Human CLDN18.2 scFv (XW-276) CD28-CD3ζ CAR, pCDCAR1 | Human | XW-276 | Mouse | 7H-YB-Fluc-EF1a-scFv-CD28-CD3ζ | Lentiviral vector | |||
XS-0822-YF8359 | TS-Fluc Anti-Mouse CLDN18.2 scFv (XW-277) CD28-CD3ζ CAR, pCDCAR1 | Mouse | XW-277 | Rat | 7H-YB-Fluc-EF1a-scFv-CD28-CD3ζ | Lentiviral vector | |||
XS-0822-YF8360 | TS-Fluc Anti-Human CLDN18.2 scFv (XW-278) CD28-CD3ζ CAR, pCDCAR1 | Human | XW-278 | Mouse | 7H-YB-Fluc-EF1a-scFv-CD28-CD3ζ | Lentiviral vector | |||
XS-0822-YF8361 | TS-Fluc Anti-Human CLDN18.2 scFv (XW-279) CD28-CD3ζ CAR, pCDCAR1 | Human | XW-279 | Mouse | 7H-YB-Fluc-EF1a-scFv-CD28-CD3ζ | Lentiviral vector | |||
XS-0822-YF8362 | TS-Fluc Anti-Human CLDN18.2 scFv (XW-280) CD28-CD3ζ CAR, pCDCAR1 | Human | XW-280 | Mouse | 7H-YB-Fluc-EF1a-scFv-CD28-CD3ζ | Lentiviral vector | |||
XS-0822-YF8363 | TS-Fluc Anti-Mouse CLDN18.2 scFv (XW-281) CD28-CD3ζ CAR, pCDCAR1 | Mouse | XW-281 | Rat | 7H-YB-Fluc-EF1a-scFv-CD28-CD3ζ | Lentiviral vector | |||
XS-0822-YF8364 | TS-Fluc Anti-Human CLDN18.2 scFv (XW-282) CD28-CD3ζ CAR, pCDCAR1 | Human | XW-282 | Mouse | 7H-YB-Fluc-EF1a-scFv-CD28-CD3ζ | Lentiviral vector | |||
XS-0822-YF8365 | TS-Fluc Anti-Human CLDN18.2 scFv (XW-283) CD28-CD3ζ CAR, pCDCAR1 | Human | XW-283 | Humanized | 7H-YB-Fluc-EF1a-scFv-CD28-CD3ζ | Lentiviral vector | |||
XS-0822-YF8366 | TS-Fluc Anti-Human CLDN18.2 scFv (XW-284) CD28-CD3ζ CAR, pCDCAR1 | Human | XW-284 | Humanized | 7H-YB-Fluc-EF1a-scFv-CD28-CD3ζ | Lentiviral vector | |||
XS-0822-YF8367 | TS-Fluc Anti-Human CLDN18.2 scFv (XW-285) CD28-CD3ζ CAR, pCDCAR1 | Human | XW-285 | Mouse | 7H-YB-Fluc-EF1a-scFv-CD28-CD3ζ | Lentiviral vector | |||
XS-0823-LX29 | Anti-hCLDN18.2 (182511) ICD(CD28-OX40-CD3ζ) CAR-MA, pAd5f35 Vector | Human | 182511 | Adenoviral vectors |
The latest newsletter to introduce the latest breaking information, our site updates, field and other scientific news, important events, and insights from industry leaders
LEARN MORE NEWSLETTERCellRapeutics™ In Vivo Cell Engineering: One-stop in vivo T/B/NK cell and macrophage engineering services covering vectors construction to function verification.
LEARN MORE SOLUTIONSilence™ CAR-T Cell: A novel platform to enhance CAR-T cell immunotherapy by combining RNAi technology to suppress genes that may impede CAR functionality.
LEARN MORE NOVEL TECHNOLOGYCanine CAR-T Therapy Development: From early target discovery, CAR design and construction, cell culture, and transfection, to in vitro and in vivo function validation.
LEARN MORE SOLUTION